BPBT
JAZZ icon

Boston Private Bank & Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Boston Private Bank & Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$16K – 1092
2014
Q4 		$16K Hold
100
– – ﹤0.01% 784
2014
Q3 		$16K Hold
100
– – ﹤0.01% 805
2014
Q2 		$15K Hold
100
– – ﹤0.01% 775
2014
Q1 		$14K Hold
100
– – ﹤0.01% 804
2013
Q4 		$13K Buy
+100
New +$10.3K ﹤0.01% 810

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Private Bank & Trust's JAZZ Position: Q1 2015 in Review

Boston Private Bank & Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 100 shares — an estimated $16K sold.

Boston Private Bank & Trust first reported a position in JAZZ in Q4 2013 and held it in 5 quarters. The position peaked at $16K in Q4 2014. 355 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

  • Boston Private Bank & Trust reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Boston Private Bank & Trust sold 100 Jazz Pharmaceuticals shares in Q1 2015, an estimated $16K.
  • Boston Private Bank & Trust first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • Boston Private Bank & Trust's Jazz Pharmaceuticals position peaked at $16K in Q4 2014.
  • 355 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.